Lexaria Bioscience (LEXX) Return on Assets (2017 - 2026)
Lexaria Bioscience (LEXX) posted Return on Assets of 0.01% for Q2 2026, up 9.73% sequentially from 0.02% in Q1 2026, and little changed YoY from 0.01% in Q2 2025.
Lexaria Bioscience (LEXX) Return on Assets (2017 - 2026) Analysis & Trends
Lexaria Bioscience has reported Return on Assets for 10 years, with the latest figure at 0.01% in Q2 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through May 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.04%, down 1.0% from the prior year.
- Return on Assets advanced to 0.01% in Q2 2026 per LEXX's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q1 2022 and troughed at 0.54% in Q1 2023.
- A 5-year average of 0.06% and a median of 0.02% in 2022 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2023 and 2024: Return on Assets plunged 54 bps in 2023, then jumped 52 bps in 2024.
- Over 5 years, Return on Assets stood at 0.02% in 2022, then plunged by 131 bps to 0.04% in 2023, then surged by 75 bps to 0.01% in 2024, then slumped by 127 bps to 0.02% in 2025, then jumped by 35 bps to 0.01% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.02%, and 0.02% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 0.00% |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -0.01% |
| Feb 28, 2026 | -0.02% |
| Nov 30, 2025 | -0.02% |
| Aug 31, 2025 | -0.02% |
| May 31, 2025 | -0.01% |
| Feb 28, 2025 | -0.01% |
| Nov 30, 2024 | -0.01% |
| Aug 31, 2024 | -0.02% |
| May 31, 2024 | -0.02% |
| Feb 29, 2024 | -0.02% |
| Nov 30, 2023 | -0.04% |
| Aug 31, 2023 | -0.04% |
| May 31, 2023 | -0.19% |
| Feb 28, 2023 | -0.54% |
| Nov 30, 2022 | -0.02% |
| Aug 31, 2022 | -0.01% |
| May 31, 2022 | -0.01% |
| Feb 28, 2022 | 0.00% |
| Nov 30, 2021 | 0.00% |
| Aug 31, 2021 | 0.00% |